Behind the Batch Episode 5 – Matt Hewitt

In episode 5 of Behind the Batch, Matt Hewitt, Vice President and Chief Technical Officer of the Manufacturing Business Division at Charles River Laboratories, discusses where cell and gene therapy manufacturing tends to break down, why process scalability decides commercial success, how autologous and allogeneic approaches differ, and how academia and industry can work together to get therapies to patients faster.

Watch now!